Get started
Surrozen, Inc.Surrozen, Inc.Surrozen, Inc.

Surrozen, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

SRZN chart


Full chart

SRZN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪82.80 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−21.27 USD
Net income (FY)
‪−63.56 M‬ USD
Revenue (FY)
‪10.65 M‬ USD
Shares float
‪978.18 K‬
Beta (1Y)
−0.18

Employees


Employees (FY)
41
Change (1Y)
−1 −2.38%
Revenue / Employee (1Y)
‪259.88 K‬ USD
Net income / Employee (1Y)
‪−1.55 M‬ USD

About Surrozen, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Craig C. Parker
Website
surrozen.com
Headquarters
South San Francisco
Founded
2015
FIGI
BBG00XY94S95
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SRZN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as SRZN.

Frequently Asked Questions


The current price of SRZN is 9.60 USD — it has increased by 1.53% in the past 24 hours. Watch Surrozen, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Surrozen, Inc. stocks are traded under the ticker SRZN.
SRZN stock has risen by 4.57% compared to the previous week, the month change is a −14.84% fall, over the last year Surrozen, Inc. has showed a 1.05% increase.
We've gathered analysts' opinions on Surrozen, Inc. future price: according to them, SRZN price has a max estimate of 45.00 USD and a min estimate of 32.00 USD. Watch SRZN chart and read a more detailed Surrozen, Inc. stock forecast: see what analysts think of Surrozen, Inc. and suggest that you do with its stocks.
SRZN reached its all-time high on Sep 17, 2021 with the price of 209.90 USD, and its all-time low was 4.50 USD and was reached on Nov 9, 2023. View more price dynamics on SRZN chart.
See other stocks reaching their highest and lowest prices.
SRZN stock is 6.98% volatile and has beta coefficient of −0.18. Track Surrozen, Inc. stock price on the chart and check out the list of the most volatile stocks — is Surrozen, Inc. there?
Today Surrozen, Inc. has the market capitalization of ‪81.55 M‬, it has increased by 3.17% over the last week.
Yes, you can track Surrozen, Inc. financials in yearly and quarterly reports right on TradingView.
Surrozen, Inc. is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
SRZN earnings for the last quarter are −9.00 USD per share, whereas the estimation was −2.54 USD resulting in a −254.33% surprise. The estimated earnings for the next quarter are −1.09 USD per share. See more details about Surrozen, Inc. earnings.
Surrozen, Inc. revenue for the last quarter amounts to ‪700.00 K‬ USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SRZN net income for the last quarter is ‪−28.04 M‬ USD, while the quarter before that showed ‪−1.43 M‬ USD of net income which accounts for ‪−1.86 K‬% change. Track more Surrozen, Inc. financial stats to get the full picture.
No, SRZN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 22, 2025, the company has 41 employees. See our rating of the largest employees — is Surrozen, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Surrozen, Inc. EBITDA is ‪−24.10 M‬ USD, and current EBITDA margin is −226.16%. See more stats in Surrozen, Inc. financial statements.
Like other stocks, SRZN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Surrozen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Surrozen, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Surrozen, Inc. stock shows the sell signal. See more of Surrozen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.